Literature DB >> 27765459

Carboplatin-allergic patients undergoing desensitization: prevalence and impact of the BRCA 1/2 mutation.

Violeta Régnier Galvão1, Elizabeth Phillips2, Pedro Giavina-Bianchi3, Mariana C Castells4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27765459      PMCID： PMC5393958          DOI： 10.1016/j.jaip.2016.08.012

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  9 in total

Review 1.  Deciphering the BRCA1 Tumor Suppressor Network.

Authors:  Qinqin Jiang; Roger A Greenberg
Journal:  J Biol Chem       Date:  2015-06-05       Impact factor: 5.157

Review 2.  Hypersensitivity to biological agents-updated diagnosis, management, and treatment.

Authors:  Violeta Régnier Galvão; Mariana C Castells
Journal:  J Allergy Clin Immunol Pract       Date:  2015 Mar-Apr

Review 3.  Tryptase, a mediator of human mast cells.

Authors:  L B Schwartz
Journal:  J Allergy Clin Immunol       Date:  1990-10       Impact factor: 10.793

4.  BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.

Authors:  Tuya Pal; Jenny Permuth-Wey; Judith A Betts; Jeffrey P Krischer; James Fiorica; Hector Arango; James LaPolla; Mitchell Hoffman; Martin A Martino; Katie Wakeley; George Wilbanks; Santo Nicosia; Alan Cantor; Rebecca Sutphen
Journal:  Cancer       Date:  2005-12-15       Impact factor: 6.860

5.  Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies.

Authors:  David Sloane; Usha Govindarajulu; Jacob Harrow-Mortelliti; William Barry; Florence Ida Hsu; David Hong; Tanya Laidlaw; Ross Palis; Henry Legere; Supinda Bunyavanich; Rebecca Breslow; Duane Wesemann; Nora Barrett; Patrick Brennan; Hey Jin Chong; Anne Liu; James Fernandez; Laura Fanning; Timothy Kyin; Katherine Cahill; Lora Bankova; Ashly Lynch; Suzanne Berlin; Susana Campos; Charles Fuchs; Robert Mayer; Ursula Matulonis; Mariana Castells
Journal:  J Allergy Clin Immunol Pract       Date:  2016-02-16

6.  Clinical features and severity grading of anaphylaxis.

Authors:  Simon G A Brown
Journal:  J Allergy Clin Immunol       Date:  2004-08       Impact factor: 10.793

7.  Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.

Authors:  Nadine Tung; Nancy U Lin; John Kidd; Brian A Allen; Nanda Singh; Richard J Wenstrup; Anne-Renee Hartman; Eric P Winer; Judy E Garber
Journal:  J Clin Oncol       Date:  2016-03-14       Impact factor: 44.544

8.  Integrated genomic analyses of ovarian carcinoma.

Authors: 
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

9.  Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions.

Authors:  D H Moon; J-M Lee; A M Noonan; C M Annunziata; L Minasian; N Houston; J L Hays; E C Kohn
Journal:  Br J Cancer       Date:  2013-07-18       Impact factor: 7.640
  9 in total
  5 in total

Review 1.  Premedication Protocols to Prevent Hypersensitivity Reactions to Chemotherapy: a Literature Review.

Authors:  Faisal ALMuhizi; Leticia De Las Vecillas Sanchez; Lucy Gilbert; Ana M Copaescu; Ghislaine A C Isabwe
Journal:  Clin Rev Allergy Immunol       Date:  2022-03-08       Impact factor: 8.667

2.  Impact of carboplatin hypersensitivity and desensitization on patients with recurrent ovarian cancer.

Authors:  Gary Altwerger; Esther B Florsheim; Gulden Menderes; Jonathan Black; Carlton Schwab; Gregory M Gressel; Wendelin K Nelson; Nina Carusillo; Terri Passante; Gloria Huang; Babak Litkouhi; Masoud Azodi; Dan-Arin Silasi; Alessandro Santin; Peter E Schwartz; Elena S Ratner
Journal:  J Cancer Res Clin Oncol       Date:  2018-09-25       Impact factor: 4.553

Review 3.  Drug Desensitizations for Chemotherapy: Safety and Efficacy in Preventing Anaphylaxis.

Authors:  Joana Caiado; Mariana C Castells
Journal:  Curr Allergy Asthma Rep       Date:  2021-07-07       Impact factor: 4.806

Review 4.  Drug Hypersensitivity and Desensitizations: Mechanisms and New Approaches.

Authors:  Leticia de Las Vecillas Sánchez; Leila A Alenazy; Marlene Garcia-Neuer; Mariana C Castells
Journal:  Int J Mol Sci       Date:  2017-06-20       Impact factor: 5.923

Review 5.  Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: The Role of Desensitizations.

Authors:  Mariana Castells
Journal:  Front Immunol       Date:  2017-11-08       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.